We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,789 results
  1. Evaluation of seegene anyplex MTB/NTM real-time detection assay for diagnosis of tuberculous meningitis

    Background

    Tuberculous meningitis (TBM) is a common central nervous system infectious disease. Polymerase chain reaction (PCR) assay is a useful...

    Verajit Chotmongkol, Seththawut Kosallavat, ... Prajuab Chaimanee in Orphanet Journal of Rare Diseases
    Article Open access 03 January 2024
  2. A Randomized Controlled Trial of a Novel Formulation of Ketorolac Tromethamine for Continuous Infusion (NTM-001) in Healthy Volunteers

    Introduction

    There is an urgent unmet medical need for a safe, effective, nonopioid analgesic agent for postoperative pain control.

    Methods ...
    Joseph V. Pergolizzi Jr., Amanjot Batra, William K. Schmidt in Advances in Therapy
    Article 09 December 2023
  3. A deep learning model using chest X-ray for identifying TB and NTM-LD patients: a cross-sectional study

    Background

    Timely differentiating between pulmonary tuberculosis (TB) and nontuberculous mycobacterial lung disease (NTM-LD), which are...

    Chia-Jung Liu, Cheng Che Tsai, ... Chong-Jen Yu in Insights into Imaging
    Article Open access 15 April 2023
  4. Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery

    Non-tuberculous mycobacterial pulmonary disease (NTM-PD) poses a substantial patient, healthcare, and economic burden. Managing NTM-PD remains...

    Roald van der Laan, Andy Snabilié, Marko Obradovic in Respiratory Research
    Article Open access 24 December 2022
  5. Eliciting Patient Insights on the Burden of Nontuberculous Mycobacterial Lung Disease (NTM-LD) and Healthcare Gaps in Germany Through Qualitative Semi-structured Interviews

    Introduction

    Nontuberculous mycobacterial lung disease (NTM-LD) is a rare but growing health concern, particularly affecting vulnerable patients with...

    Christian Hoenig, Roald van der Laan, ... Marko Obradovic in Advances in Therapy
    Article 08 May 2023
  6. Risk factors for nontuberculous mycobacterial pulmonary disease (NTM-PD) in Croatia

    Background

    The incidence, geographical distribution and clinical relevance of different nontuberculous mycobacteria (NTM) in Croatia are well...

    Goran Glodić, Miroslav Samaržija, ... Mateja Janković Makek in Wiener klinische Wochenschrift
    Article 17 August 2021
  7. The diagnostic impact of fractional exhaled nitric oxide for asthmatic cough in nontuberculous mycobacterial pulmonary disease

    Background

    Measurement of exhaled nitric oxide (FeNO) is a potentially useful diagnostic test for asthma. However, no study has explored the...

    Mari Miki, Keisuke Miki, ... Hiroshi Kida in BMC Pulmonary Medicine
    Article Open access 29 April 2024
  8. Clinical course of nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis

    Objectives

    The impact of rheumatoid arthritis (RA) on nontuberculous mycobacterial pulmonary disease (NTM-PD) has not been well established. In this...

    Nakwon Kwak, **young Moon, ... Jae-Joon Yim in Advances in Rheumatology
    Article Open access 15 March 2024
  9. Nodular distribution pattern on chest computed tomography (CT) in patients diagnosed with nontuberculous mycobacteria (NTM) infections

    Background

    This study evaluated the prevalence of spreading pathways in nontuberculous mycobacteria (NTM) pulmonary infections according to nodular...

    Ante Marušić, Ivana Kuhtić, ... Lucija Stanić in Wiener klinische Wochenschrift
    Article 02 July 2020
  10. Nontuberculous mycobacteria testing and culture positivity in the United States

    Background

    Nontuberculous mycobacteria (NTM) are environmental bacteria which may cause chronic lung disease. The prevalence of NTM pulmonary...

    Julia E. Marshall, Rachel A. Mercaldo, ... D. Rebecca Prevots in BMC Infectious Diseases
    Article Open access 06 March 2024
  11. Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambaréné, Gabon—a cross-sectional study

    Background

    Non-tuberculous mycobacteria (NTM) are a group of bacteria that cause rare lung infections and are increasingly recognized as causative...

    Micheska Epola Dibamba Ndanga, Jabar Babatundé Pacome Achimi Agbo Abdul, ... Ayola Akim Adegnika in BMC Infectious Diseases
    Article Open access 03 October 2023
  12. The additional value of 18F-FDG PET/CT imaging in guiding the treatment strategy of non-tuberculous mycobacterial patients

    Objectives

    Non-tuberculous mycobacteria (NTM) infection is an increasing health problem due to delaying an effective treatment. However, there are few...

    Donghe Chen, Yunbo Chen, ... **nhui Su in Respiratory Research
    Article Open access 18 March 2024
  13. Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010–2019)

    Background

    Nontuberculous mycobacteria (NTM) are ubiquitous, environmental bacteria that can cause chronic lung disease. Persons with cystic fibrosis...

    Julia E. Marshall, Rachel A. Mercaldo, ... D. Rebecca. Prevots in BMC Infectious Diseases
    Article Open access 24 July 2023
  14. The successful treatment of microscopic polyangiitis associated with non-tuberculous mycobacterial-pulmonary disease

    While the incidence and prevalence of non-tuberculous mycobacterial-pulmonary disease (NTM-PD) are increasing and microscopic polyangiitis (MPA) is...

    Ryuichi Yoshii, Kengo Kajiwara, ... Masashi Mukoyama in CEN Case Reports
    Article 09 December 2023
  15. Pneumologie meets Infektiologie: Nichttuberkulöse Mykobakteriosen der Lunge

    Background

    Nontuberculous mycobacterial infections of the lung (NTM-LD) are diseases with a chronic course, that often occur in conjunction with...

    Espen E. Groth, Elena Terhalle in Wiener klinisches Magazin
    Article 20 October 2023
  16. Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine

    Background

    Non-tuberculous mycobacteria (NTM) are generally free-living organism, widely distributed in the environment, with sporadic potential to...

    A. Calcagno, N. Coppola, ... D. Goletti in Infection
    Article Open access 08 February 2024
  17. Nontuberculous Mycobacterial Infections and Management for the Inpatient Dermatologist

    Purpose of Review

    To improve recognition of skin and soft tissue infections caused by nontuberculous mycobacteria (NTM) and provide guidance on...

    Amber Y. Bo, Laura E. Goeser, Karolyn A. Wanat in Current Dermatology Reports
    Article 28 December 2023
  18. Validity of claims-based diagnoses for infectious diseases common among immunocompromised patients in Japan

    Background

    To validate Japanese claims-based disease-identifying algorithms for herpes zoster (HZ), Mycobacterium tuberculosis (MTB), nontuberculous...

    Ryota Hase, Daisuke Suzuki, ... Soko Setoguchi in BMC Infectious Diseases
    Article Open access 03 October 2023
  19. Usefulness of the mini nutritional assessment short-form for evaluating nutritional status in patients with nontuberculous mycobacterial pulmonary disease: a prospective cross-sectional study

    Background

    Although the Mini Nutritional Assessment (MNA) is recognized as a useful tool for evaluating nutritional status in patients with various...

    Eunki Chung, Youngmok Park, ... Young Ae Kang in BMC Infectious Diseases
    Article Open access 19 June 2024
  20. Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database

    Background

    The Center for Personalized Precision Medicine of Tuberculosis (cPMTb) was constructed to develop personalized pharmacotherapeutic systems...

    Woo Jung Seo, Hyeon-Kyoung Koo, ... Yong-Soon Cho in BMC Pulmonary Medicine
    Article Open access 24 November 2023
Did you find what you were looking for? Share feedback.